- Home
- CCO vs CRMD Comparison
CCO vs CRMD Comparison
Compare CCO & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCO
- CRMD
- Stock Information
- Founded
- CCO 1995
- CRMD 2006
- Country
- CCO United States
- CRMD United States
- Employees
- CCO N/A
- CRMD N/A
- Industry
- CCO Advertising
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- CCO Consumer Discretionary
- CRMD Health Care
- Exchange
- CCO Nasdaq
- CRMD Nasdaq
- Market Cap
- CCO 735.6M
- CRMD 865.2M
- IPO Year
- CCO 2005
- CRMD 2010
- Fundamental
- Price
- CCO $1.35
- CRMD $10.98
- Analyst Decision
- CCO Hold
- CRMD Strong Buy
- Analyst Count
- CCO 5
- CRMD 8
- Target Price
- CCO $1.78
- CRMD $17.57
- AVG Volume (30 Days)
- CCO 3.7M
- CRMD 2.6M
- Earning Date
- CCO 11-06-2025
- CRMD 10-29-2025
- Dividend Yield
- CCO N/A
- CRMD N/A
- EPS Growth
- CCO N/A
- CRMD N/A
- EPS
- CCO 0.04
- CRMD 0.79
- Revenue
- CCO $1,538,895,000.00
- CRMD $121,484,498.00
- Revenue This Year
- CCO $6.16
- CRMD $480.51
- Revenue Next Year
- CCO $4.01
- CRMD $59.81
- P/E Ratio
- CCO $30.92
- CRMD $13.90
- Revenue Growth
- CCO 31.61
- CRMD 14970.29
- 52 Week Low
- CCO $0.81
- CRMD $5.60
- 52 Week High
- CCO $1.69
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- CCO 44.75
- CRMD 41.63
- Support Level
- CCO $1.41
- CRMD $11.05
- Resistance Level
- CCO $1.59
- CRMD $11.71
- Average True Range (ATR)
- CCO 0.08
- CRMD 0.47
- MACD
- CCO -0.02
- CRMD 0.01
- Stochastic Oscillator
- CCO 5.65
- CRMD 8.21
About CCO Clear Channel Outdoor Holdings Inc.
Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.